90 related articles for article (PubMed ID: 14738137)
1. Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.
Barragán M; Campàs C; Bellosillo B; Gil J
Leuk Lymphoma; 2003 Nov; 44(11):1865-70. PubMed ID: 14738137
[TBL] [Abstract][Full Text] [Related]
2. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.
Barragán M; Bellosillo B; Campàs C; Colomer D; Pons G; Gil J
Blood; 2002 Apr; 99(8):2969-76. PubMed ID: 11929788
[TBL] [Abstract][Full Text] [Related]
3. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.
Ringshausen I; Schneller F; Bogner C; Hipp S; Duyster J; Peschel C; Decker T
Blood; 2002 Nov; 100(10):3741-8. PubMed ID: 12393602
[TBL] [Abstract][Full Text] [Related]
4. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.
Plate JM
Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
6. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways.
Wang K; Scheel-Toellner D; Wong SH; Craddock R; Caamano J; Akbar AN; Salmon M; Lord JM
J Immunol; 2003 Jul; 171(2):1035-41. PubMed ID: 12847277
[TBL] [Abstract][Full Text] [Related]
8. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
9. Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance.
Iglesias-Serret D; Piqué M; Barragán M; Cosialls AM; Santidrián AF; González-Gironès DM; Coll-Mulet L; de Frias M; Pons G; Gil J
Apoptosis; 2010 Feb; 15(2):219-29. PubMed ID: 19936928
[TBL] [Abstract][Full Text] [Related]
10. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition.
Alkan S; Huang Q; Ergin M; Denning MF; Nand S; Maududi T; Paner GP; Ozpuyan F; Izban KF
Am J Hematol; 2005 Jun; 79(2):97-106. PubMed ID: 15929099
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
Ringshausen I; Dechow T; Schneller F; Weick K; Oelsner M; Peschel C; Decker T
Leukemia; 2004 Dec; 18(12):1964-70. PubMed ID: 15483673
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the role of protein kinase C in chronic lymphocytic leukaemia.
Michie AM; Nakagawa R
Hematol Oncol; 2006 Sep; 24(3):134-8. PubMed ID: 16841369
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
16. Defects in signal transduction pathways in chronic B lymphocytic leukemia cells.
Jabbar SA; Hoffbrand AV; Wickremasinghe RG
Leuk Lymphoma; 1995 Jun; 18(1-2):163-70. PubMed ID: 8580820
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.
Lutzny G; Kocher T; Schmidt-Supprian M; Rudelius M; Klein-Hitpass L; Finch AJ; Dürig J; Wagner M; Haferlach C; Kohlmann A; Schnittger S; Seifert M; Wanninger S; Zaborsky N; Oostendorp R; Ruland J; Leitges M; Kuhnt T; Schäfer Y; Lampl B; Peschel C; Egle A; Ringshausen I
Cancer Cell; 2013 Jan; 23(1):77-92. PubMed ID: 23328482
[TBL] [Abstract][Full Text] [Related]
18. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CbetaII.
Abrams ST; Lakum T; Lin K; Jones GM; Treweeke AT; Farahani M; Hughes M; Zuzel M; Slupsky JR
Blood; 2007 Feb; 109(3):1193-201. PubMed ID: 17003377
[TBL] [Abstract][Full Text] [Related]
19. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
20. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]